Maharaj, K., Powers, J. J., Mediavilla-Varela, M., Achille, A., Gamal, W., Quayle, S., . . . Pinilla-Ibarz, J. (2020). HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. Front Immunol.

Maharaj, Kamira, John J. Powers, Melanie Mediavilla-Varela, Alex Achille, Wael Gamal, Steven Quayle, Simon S. Jones, Eva Sahakian, and Javier Pinilla-Ibarz. "HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model." Front Immunol 2020.

Maharaj, Kamira, et al. "HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model." Front Immunol 2020.